References
- Go AS, Mozaffarian D, Roger VL, et al. Executive summary: heart disease and stroke statistics-2014 update a report from the American heart association. Circulation. 2014;129(3):399–410.
- Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics-2014 update a report from the American heart association. Circulation. 2014;129(3):E28–E292.
- Jauch EC, Saver HP, Adamsjr HP, et al. Guidelines for the early management of patients with acute ischemic stroke: executive summary a guideline for healthcare professionals from the American heart association/American stroke association. Stroke. 2013;44(3):870–948.
- Rundek T, Sacco RL. Risk factor management to prevent first stroke. Neurol Clin. 2008;26(4):1007–1045.
- Gallanagh S, Quinn TJ, Alexander J, et al. Physical activity in the prevention and treatment of stroke. ISRN Neurol. 2011;2011:953818.
- Davis S, Lees K, Donnan G. Treating the acute stroke patient as an emergency: current practices and future opportunities. Int J Clin Pract. 2006;60(4):399–407.
- Musuka TD, Wilton SB, Traboulsi M, et al. Diagnosis and management of acute ischemic stroke: speed is critical. Can Med Assoc J. 2015;187(12):887–893.
- Donnan GA, Fisher M, Macleod M, et al. Stroke. Lancet. 2008;371(9624):1612–1623.
- Feigin VL, Norrving B, Mensah GA. Global burden of stroke. Circ Res. 2017;120(3):439–448.
- Smith JV, Luo Y. Studies on molecular mechanisms of Ginkgo biloba extract. Appl Microbiol Biotechnol. 2004;64(4):465–472.
- Zimmermann M, Colciaghi F, Cattabeni F, et al. Ginkgo biloba extract: from molecular mechanisms to the treatment of Alzhelmer’s disease. Cell Mol Biol (Noisy-Le-Grand). 2002;48(6):613–623.
- Charemboon T, Jaisin K. Ginkgo biloba for prevention of dementia: a systematic review and meta-analysis. J Med Assoc Thai. 2015;98(5):508–513.
- Garg RK, Nag D, Agrawal A. A double blind placebo controlled trial of ginkgo biloba extract in acute cerebral ischaemia. J Assoc Physicians India. 1995;43(11):760–763.
- Anadere I, Chmiel H, Witte S. Hemorheological findings in patients with completed stroke and the influence of a Ginkgo biloba extract. Clin Hemorheol. 1985;5(5):411–420.
- Nash KM, Shah ZA. Current perspectives on the beneficial role of Ginkgo biloba in neurological and cerebrovascular disorders. Integr Med Insights. 2015;10:1–9.
- Liu JP. The use of Ginkgo biloba extract in acute ischemic stroke. Explor J Sci Heal. 2006;2(3):262–263.
- Li S, Zhang X, Fang Q, et al. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial. Stroke Vasc Neurol. 2017;2(4):189–197.
- von Gunten A, Schlaefke S, Uberla K. Efficacy of Ginkgo biloba extract EGb 761((R)) in dementia with behavioural and psychological symptoms: a systematic review. World J Biol Psychiatry. 2016;17(8):622–633.
- Krieglstein J, Beck T, Seibert A. Influence of an extract of Ginkgo biloba on cerebral blood flow and metabolism. Life Sci. 1986;39(24):2327–2334.
- Zhang WR, Hayashi T, Kitagawa H, et al. Protective effect of ginkgo extract on rat brain with transient middle cerebral artery occlusion. Neurol Res. 2000;22(5):517–521.
- Lee EJ, Chen HY, Wu TS, et al. Acute administration of Ginkgo biloba extract (EGb 761) affords neuroprotection against permanent and transient focal cerebral ischemia in Sprague-Dawley rats. J Neurosci Res. 2002;68(5):636–645.
- Son JK, Son MJ, Lee E, et al. Ginkgetin, a Biflavone from Ginko biloba leaves, inhibits cyclooxygenases-2 and 5-lipoxygenase in mouse bone marrow-derived mast cells. Biol Pharm Bull. 2005;28(12):2181–2184.
- Larpthaveesarp A, Gonzalez FF. Transient middle cerebral artery occlusion model of neonatal stroke in P10 rats. J Vis Exp. 2017;122:54830.
- Hill JW, Nemoto EM. Transient middle cerebral artery occlusion with complete reperfusion in spontaneously hypertensive rats. MethodsX. 2014;1:283–291.
- Bederson JB, Pitts LH, Tsuji M, et al. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 1986;17(3):472–476.
- Guo M, Suo Y, Gao Q, et al. The protective mechanism of Ginkgolides and Ginkgo flavonoids on the TNF-alpha induced apoptosis of rat hippocampal neurons and its mechanisms in vitro. Heliyon. 2015;1(1):e00020.
- Jiang M, Li J, Peng Q, et al. Neuroprotective effects of bilobalide on cerebral ischemia and reperfusion injury are associated with inhibition of pro-inflammatory mediator production and down-regulation of JNK1/2 and p38 MAPK activation. J Neuroinflamm. 2014;11:167.
- Kwak WJ, Han CK, Son KH, et al. Effects of Ginkgetin from Ginkgo biloba Leaves on cyclooxygenases and in vivo skin inflammation. Planta Med. 2002;68(4):316–321.
- Lester SN, Li K. Toll-like receptors in antiviral innate immunity. J Mol Biol. 2014;426(6):1246–1264.
- Galiana-Arnoux D, Imler JL. Toll-like receptors and innate antiviral immunity. Tissue Antigens. 2006;67(4):267–276.
- Lu YC, Yeh WC, Ohashi PS. LPS/TLR4 signal transduction pathway. Cytokine. 2008;42(2):145–151.
- Tsung A, Hoffman RA, Izuishi K, et al. Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J Immunol. 2005;175(11):7661–7668.
- Hua F, Ma J, Ha T, et al. Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion. J Neuroimmunol. 2007;190(1–2):101–111.
- van Delft MA, Huitema LF, Tas SW. The contribution of NF-kappaB signalling to immune regulation and tolerance. Eur J Clin Invest. 2015;45(5):529–539.
- Harari OA, Liao JK. NF-kappaB and innate immunity in ischemic stroke. Ann N Y Acad Sci. 2010;1207:32–40.
- Zhao H, Chen Z, Xie LJ, et al. Suppression of TLR4/NF-kappaB signaling pathway improves cerebral ischemia-reperfusion injury in rats. Mol Neurobiol. 2018;55(5):4311–4319.
- Wu H, Chen G, Wyburn KR, et al. TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest. 2007;117(10):2847–2859.
- Zhao H, Perez JS, Lu K, et al. Role of Toll-like receptor-4 in renal graft ischemia-reperfusion injury. Am J Physiol Renal Physiol. 2014;306(8):F801–11.
- Yang Y, Lv J, Jiang S, et al. The emerging role of Toll-like receptor 4 in myocardial inflammation. Cell Death Dis. 2016;7:e2234.
- Wang C, Sun H, Song Y, et al. Pterostilbene attenuates inflammation in rat heart subjected to ischemia-reperfusion: role of TLR4/NF-kappaB signaling pathway. Int J Clin Exp Med. 2015;8(2):1737–1746.